RxDoctor Payments Data

Bryan Vopat, MD

Orthopaedic Surgery · Kansas City, KSNPI 1922260462

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Stryker at 56.9% of the total. 2025 is the largest year on record at $6,704, 6.7 times the $1,006 reported in 2019.

$21,780in general payments, 2019–2025

Across 176 payments — averaging $123.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$12K
  • International Life Sciences$4K
  • Novastep Inc.$2K
  • Vericel Corporation$1K
  • Titan Surgical Group, LLC$1K
  • Depuy Synthes Products, Inc.$585
  • plus $720 from 13 others
$34,555in research payments, 2019–2025

Across 5 payments — averaging $6910.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$34K
  • Arthrex$1K

What the payments were for

  • Consulting fees$9,51044%
  • Travel & lodging$4,24619%
  • Food & beverage$6,74631%
  • Education$1,2006%
  • Gifts$790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,780 in reported general payments places this provider in the 80th percentile of 197 orthopaedic surgery providers in Kansas.

See all orthopaedic surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$37,632
Medicare patients
110
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib13$476

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →